Abstract
The initial description of clinical radiation biology arose in an era where most external beam treatments comprised multiple fractions of radiation delivered over a protracted period of time. The increasing adoption of image guided techniques has permitted the delivery of much larger single doses over shorter time periods. In this chapter we discuss those biological factors thought to impact clinical outcome, repair, reoxygenation, redistribution, repopulation, and radiosensitivity and compare and contrast their relevance in the era of hypofractionated treatment.
Keywords
- Stereotactic Body Radiotherapy
- Linear Quadratic
- Mitotic Catastrophe
- Conventional Fractionation
- Normal Tissue Toxicity
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–8.
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60.
Chan N, Koritzinsky M, Zhao H, Bindra R, Glazer PM, et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008;68:605–14.
Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984;2:317–23.
Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8:89–91.
Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol. 2004;49:4825–35.
Hammond EM, Dorie MJ, Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem. 2003;278:12207–13.
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509–15.
Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071–8.
Malaise EP, Fertil B, Deschavanne PJ, Chavaudra N, Brock WA. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res. 1987;111:319–33.
Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–52.
Reddy SB, Williamson SK. Tirapazamine: a novel agent targeting hypoxic tumor cells. Expert Opin Investig Drugs. 2009;18:77–87.
Rischin D, Peters LJ, O’Sullivan B, Giralt J, Fisher R, et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. J Clin Oncol. 2010;28:2989–95.
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.
Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, et al. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model. J Radiat Res. 2012;53:1–9.
Surova O, Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene. 2013;32:3789–97.
Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. gammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res. 2013;753:24–40.
Withers HR. Biologic basis for altered fractionation schemes. Cancer. 1985;55:2086–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vaughan, A., Rao, S.S.D. (2016). Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. In: Sethi, R., Barani, I., Larson, D., Roach, III, M. (eds) Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-21897-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-21897-7_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21896-0
Online ISBN: 978-3-319-21897-7
eBook Packages: MedicineMedicine (R0)